Latest financial market updates and expert analysis
Analysis Ocugen has given investors two dates to circle, and they sit barely three months apart. The first is the expected release of pooled Phase III results for OCU400 in the...
XPeng used a brand event in Dubai on 2 November to parade its GX and G9L SUV flagships alongside what...
Xiaomi returned to the buyback window for a second consecutive trading day, repurchasing roughly 1.73 million Class B shares for...
Two of Europe’s best-known brokerage houses have reaffirmed their bullish stance on Voestalpine, even as one of them trimmed its...
Goldman Sachs and UBS both stuck with their buy ratings on Take-Two Interactive this week, but the two brokerages pulled...
JPMorgan’s double downgrade lands as CSG bets on a late-year revenue catch-up CSG entered Thursday with a fresh contract in...
Marvell Technology’s planned acquisition of Lumentum Holdings will not close before the first calendar half of 2028, the company confirmed...
OHB’s latest quarterly report landed with a thud on Thursday, and the market’s verdict was blunt: the stock closed down...
AGNC Investment closed the books on a bruising third quarter of 2026 with a comprehensive loss of $1.28 per diluted...
Ocugen used the Stifel Healthcare Conference to sketch the full breadth of its ocular gene therapy pipeline β three programs,...
SK Hynix has given investors two very different yardsticks to judge it by. One is a product transition: the memory...
